Pages that link to "Q38337292"

The following pages link to Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16). (Q38337292):

Displaying 14 items.

• The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers (Q21260410) (← links)
• Targeting bromodomains: epigenetic readers of lysine acetylation (Q28238635) (← links)
• Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism (Q28256059) (← links)
• Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy (Q28269627) (← links)
• A microhomology-mediated break-induced replication model for the origin of human copy number variation (Q33404060) (← links)
• Cis-regulatory elements are harbored in Intron5 of the RUNX1 gene. (Q35127261) (← links)
• Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot (Q35221459) (← links)
• Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. (Q35865072) (← links)
• Alu elements mediate MYB gene tandem duplication in human T-ALL (Q36294397) (← links)
• Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase II alpha, DNA topoisomerase II beta, and nucleolin with BCR 2 of the ETO gene (Q38356467) (← links)
• Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias (Q40298309) (← links)
• Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). (Q51768538) (← links)
• High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints. (Q53527995) (← links)
• Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia (Q90266900) (← links)